VANCOUVER, BC–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the Company will present at the upcoming Ladenburg Thalmann Healthcare Conference on July 14,… Read More
VANCOUVER, BC –(BUSINESS WIRE)–SaNOtize Research and Development Corporation (“SaNOtize” or “the Company”) today announced that Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS) that protects from viruses and was shown to… Read More
VANCOUVER, B.C. –(Newsfile Corp.) – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”) is pleased to announce that the Company has received formal conditional approval from the… Read More
CAMBRIDGE, MASS. and New York, NY– Today, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence… Read More
VANCOUVER, BC / ACCESSWIRE / — RepliCel Life Sciences Inc. (OTC PINK:REPCF) (TSXV:RP) (FSE:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to… Read More
